Lopinavir and ritonavir

NDC 31722-603 · Camber Pharmaceuticals, Inc.

Generic nameLopinavir and ritonavir

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)LOPINAVIR, RITONAVIR

Strength100; 25 mg/1; mg/1

Pharmacologic classBreast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]

Marketing categoryANDA

Packages

31722-603-12 — 120 TABLET, FILM COATED in 1 BOTTLE (31722-603-12)

31722-603-60 — 60 TABLET, FILM COATED in 1 BOTTLE (31722-603-60)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0074-2340 — Ritonavir, 0074-3008 — Lopinavir and Ritonavir, 0074-3399 — Ritonavir, 0074-3956 — Lopinavir and Ritonavir, 0074-4014 — Lopinavir and Ritonavir, 31722-556 — Lopinavir and ritonavir, 31722-597 — Ritonavir, 33342-163 — Lopinavir and Ritonavir, 33342-164 — Lopinavir and Ritonavir, 42385-933 — Lopinavir and Ritonavir, 42385-934 — Lopinavir and Ritonavir, 60687-420 — Ritonavir, 63629-5702 — Ritonavir, 65162-061 — Ritonavir, 65862-687 — Ritonavir, 68071-3898 — Ritonavir, 69097-655 — ritonavir 100 mg, 71335-2610 — Ritonavir

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.